285 search results for “drug” in the Staff website
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.
-
Student alcohol and drug abuse: what can staff do?
It’s vital that universities are able to recognise the signs of alcohol and drug misuse in students. Staff also have an important role to play in talking about substance use. ‘That one conversation can make a difference’, says Jitske Hoogervorst, an adviser at Brijder addiction treatment services.
-
Skin researcher calls for multidisciplinary collaboration: ‘I want to pool expertise’
In dermatology, there should be a high level of multidisciplinary collaboration among institutes and specialists, Professor of Translational Dermatology, Robert Rissmann, will say in his inaugural lecture on 8 July. He is building an infrastructure that will put pre-clinical and clinical skin research…
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
-
Meiling Gao -
Eline DekeysterFaculty of Social and Behavioural Sciences
-
Madeline Kavanagh -
Margo Dona -
RARE-NL: LUMC joins consortium to find treatments for rare diseases
RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the LUMC in the initiative.
-
Doctors discover a simple method to predict the risk of brain tumour recurrence
The risk of a brain tumour recurring can be predicted more accurately by counting the number of immune cells in the tumour under a microscope. These are the findings from research conducted by LUMC, Erasmus MC and Heidelberg University.
-
ICT-contact persons
For each university unit, the ICT Shared Service Centre (ISSC) has an appointed ICT contact person responsible for applying for ICT facilities for research, teaching and operational management.
-
Marije Niemeijer -
Bas ter Braak -
Vici grants for research into antibodies, galaxies and Indigenous communities
Three Leiden researchers have been awarded a Vici grant by the Dutch Research Council. The funding of up to 1.5 million euros supports ‘talented, adventurous and pioneering researchers’. A total of 39 projects at Dutch institutions will receive a grant.
-
Anthe Janssen -
Sebastian Pomplun -
Coen van Hasselt -
Erik Danen -
Daisy Batenburg -
Andraniek Evadgian -
Kim Elbertse -
Elsa Neubert -
Serkan Aslan -
Irene Pascual Garcia -
Myrtille Koerselman -
Kostas Tassis
-
Leo Price
-
Marc Boef
-
Nada Badr
-
Bola Khalil -
Matthijs Vlasveld -
Linde Schoenmaker -
Daan Jiskoot -
Chiel Jespers
-
Rosan Kuin -
Nasi Liu -
Annaloes Fokkelman-Klip -
Kirsten Veltman -
Xiaobing Zhang -
Lukas Wijaya -
Sabine de Winter -
Linglu Xu -
Britt Duijndam -
Lucy Sinke -
Mick van Schaick -
Gerard Mulder
-
Arnoud Sonnenberg
-
Natasha Tahir